Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Oncotarget|June 25, 2020
Reassessing the role of high dose cytarabine and mitoxantrone in relapsed/refractory acute myeloid leukemiaJonathan Canaani, Meital Nagar, Gabriel Heering, et al.
Journal of Clinical Immunology|October 8, 2011
Anti-T lymphocyte globulin (ATG) induces generation of regulatory T cells, at least part of them express activated CD44Orly Shimony, Arnon Nagler, Yechiel N Gellman, et al.
Bone Marrow Transplantation|December 3, 2020
Immune imitation of tumor progression after anti-CD19 chimeric antigen receptor T cells treatment in aggressive B-cell lymphomaIvetta Danylesko, Roni Shouval, Noga Shem-Tov, et al.
Oncotarget|November 24, 2016
Immunological effects of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or philadelphia chromosome-positive acute lymphoblastic leukemiaNira Varda-Bloom, Ivetta Danylesko, Roni Shouval, et al.
Leukemia & Lymphoma|August 11, 2023
Point-of-care anti-CD19 chimeric antigen receptor T-cell therapy for relapsed/refractory follicular lymphomaShalev Fried, Eden Shkury, Orit Itzhaki, et al.
Transplantation and Cellular Therapy|February 26, 2022
Point-of-care anti-CD19 CAR T-cells for treatment of relapsed and refractory aggressive B-cell lymphomaMeirav Kedmi, Roni Shouval, Shalev Fried, et al.
Rheumatology (Oxford, England)|April 5, 2026
Anti-CD19 CAR-T cell therapy as rescue treatment in systemic sclerosis relapsing after autologous hematopoietic stem cell transplantation: a case seriesDoron Rimar, Paula David, Elad Jacoby, et al.
Blood Advances|January 8, 2025
Pretreatment pulmonary function testing has limited utility in B-cell lymphoma treated with CD19 CAR T cellsInbal Sdayoor, Roni Shouval, Shalev Fried, et al.
Genome Medicine|July 17, 2025
Microbiome-based prediction of allogeneic hematopoietic stem cell transplantation outcomeOshrit Shtossel, Adi Eshel, Shalev Fried, et al.
Bone Marrow Transplantation|January 11, 2024
Fecal microbiota transplantation in capsules for the treatment of steroid refractory and steroid dependent acute graft vs. host disease: a pilot studyIlan Youngster, Adi Eshel, Mika Geva, et al.
Pageof 7